MXL Comercial, SA de CV Warning Letter Details

Summary

Based on limited metadata, this FDA Warning Letter was issued to MXL Comercial, SA de CV, a drug manufacturer, on November 10, 2020. Without access to the full letter text or specific subject line, the exact nature of the violations cannot be determined from the available information. The warning falls under FDA's drug product regulatory authority, though the specific issuing office is not identified in the metadata provided. Additional documentation would be needed to identify the particular manufacturing, labeling, or compliance deficiencies cited in the letter.